Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes
详细信息 查看全文
- 作者：Min-Shen Chung (1)
Yao-Chi Chuang (3)
Jong-Jer Lee (2)
Wei-Chia Lee (3)
Michael B. Chancellor (4)
Rue-Tsuan Liu (1) - 关键词：Nocturia ; Diabetes ; Overactive bladder
- 刊名：International Urology and Nephrology
- 出版年：2014
- 出版时间：July 2014
- 年：2014
- 卷：46
- 期：7
- 页码：1269-1275
- 全文大小：248 KB
- 参考文献：1. van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: report from the standardisation sub-committee of the international continence society. Neurourol Urodynam 21:179-83 CrossRef
2. van Dijk L, Kooij DG, Schellevis FG (2002) Nocturia in the Dutch adult population. BJU Int 90:644-48 CrossRef
3. Fitzgerald MP, Litman HJ, Link CL, McKinlay JB (2007) The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 177:1385-389 CrossRef
4. Ruud Bosch JLH, Weiss JP (2010) The prevalence and causes of nocturia. J Urol 184:440-46 CrossRef
5. Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306-315 CrossRef
6. Liu RT, Chung MS, Lee WC et al (2011) Prevalence of overactive bladder (OAB) and associated risk factors in 1,359 patients with type 2 diabetes. Urology 78:1040-045 CrossRef
7. Gulur DM, Mevcha AM, Drake MJ (2011) Nocturia as a manifestation of systemic disease. BJU Int 107:702-13 CrossRef
8. Yoshimura K (2012) Correlates for nocturia: a review of epidemiological studies. Int J Urol 19:317-29 CrossRef
9. Yamaguchi C, Sakakibara R, Uchiyama T et al (2007) Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodynam 26:807-13 CrossRef
10. Yoshimura N, Chancellor MB, Andersson KE et al (2005) Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 95:733-38 CrossRef
11. Homma Y, Yoshida M, Seki N et al (2006) Symptom assessment tool for overactive bladder syndrome: overactive bladder symptom score. Urology 68:318-23 CrossRef
12. Liew LC, Tiong HY, Wong ML et al (2006) A population study of nocturia in Singapore. BJU Int 97:109-12 CrossRef
13. Tibaek S, Gard G, Klarskov P et al (2008) Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn 27:763-71 CrossRef
14. Hsu CY, Iribarren C, McCulloch CE et al (2009) Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 169:342-50 CrossRef
15. Calhoun DA, Harding SM (2010) Sleep and hypertension. Chest 138:434-43 CrossRef
16. Subak LL, Whitcomb E, Shen H et al (2005) Weight loss: a novel and effective treatment for urinary incontinence. J Urol 174:190-95 CrossRef
17. Tai HC, Chung SD, Ho CH et al (2010) Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab 95:1143-150 CrossRef
18. Wu MY, Wu YL, Hsu YH, Lin YF, Fan YC, Lin YC, Chang SJ (2012) Risks of nocturia in patients with chronic kidney disease- doe the metabolic syndrome and its components matter? J Urol 188:2269-273 CrossRef
19. Kupelian V, McVary KT, Barry MJ et al (2009) Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Bostonarea community health survey. Urology 73:950-57 CrossRef
20. Lu Z, Gao Y, Tan A et al (2012) Increased high-sensitivity C-reactive protein predicts a high risk of lower urinary tract symptoms in Chinese male: results from the Fangchenggang Area Male Health and Examination Survey. Prostate 72:193-00 CrossRef
21. van Doorn B, Kok ET, Blanker MH et al (2012) Mortality in older men with nocturia. A 15-year followup of the Krimpen study. J Urol 187:1727-731 CrossRef
22. Kupelian V, Fitzgerald MP, Kaplan SA et al (2011) Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol 185:571-77 CrossRef
23. Asplund R (1999) Mortality in the elderly in relation to nocturnal micturition. BJU Int 84:297-01 CrossRef - 作者单位：Min-Shen Chung (1)
Yao-Chi Chuang (3)
Jong-Jer Lee (2)
Wei-Chia Lee (3)
Michael B. Chancellor (4)
Rue-Tsuan Liu (1)
1. Division of Metabolism, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung District, Kaohsiung, 833, Taiwan
3. Division of Urology, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung District, Kaohsiung, 833, Taiwan
2. Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan
4. Department of Urology, William Beaumont Hospital, Royal Oak, MI, USA - ISSN：1573-2584
文摘
Objective To evaluate the correlates of nocturia and subsequent mortality in patients with type 2 diabetes mellitus (T2DM). Methods A self-administered questionnaire containing overactive bladder symptom score was obtained from subjects with T2DM. Nocturia and severe nocturia were defined as rising ? or ? per night to void, respectively. Patient characteristics and diabetes-related complications to risk of nocturia were evaluated. Results Of 1,301 consecutive subjects, 59.6 and 25.3?% reported having nocturia and severe nocturia, respectively. The presence and severity of nocturia increased with age and overactive bladder (OAB). The presence of OAB was 28.8?% in patients with nocturia and was significantly associated with nocturia (OR 2.26) after adjustment for age and duration of DM. The presence of stroke, calcium channel blocker use, hypertension, waist circumference greater than standard, albuminuria, and higher serum creatinine level, and high-sensitivity C-reactive protein was associated with nocturia and severe nocturia after adjustment for age, duration of DM, and the presence of OAB. Higher estimated glomerular filtration rate, hemoglobin, serum albumin, and male gender were less likely to have nocturia (OR P?=?0.001) in 2.5?years follow-up. Conclusions While OAB is an important predictor of nocturia in T2DM patients, systemic issues, including stroke, hypertension, obesity, and chronic kidney disease, have further impact on nocturia independent of OAB. Severe nocturia is a marker for increased mortality.